International Lyme and Assoc Disea… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2006

Legal Domicile

Phone

3012631080

Tax Period

2023-01-01 to 2023-12-31

International Lyme and Assoc Disease Soc, founded in 2006, is a small nonprofit in the Community Improvement sector that reported $992K in total revenue in fiscal year 2023.

Mission

An international medical society whose mission is to disseminate scientific knowledge and enhance clinical expertise relating to Lyme and associated diseases. Supports a collaborative effort among scientists, researchers, healthcare providers, and others.

Program Service Accomplishments

Program 1

Expenses: $332,889 Revenue: $669,821

ILADS holds an annual scientific conference to advance the clinical knowledge, diagnosis, and treatment of Lyme and associated vector-borne diseases. Sessions are designed to teach medical...

ILADS holds an annual scientific conference to advance the clinical knowledge, diagnosis, and treatment of Lyme and associated vector-borne diseases. Sessions are designed to teach medical professionals the cutting-edge techniques of diagnosis and treatment explore pathophysiological mechanisms of chronic diseases, enhance collaboration between community clinicians and university scientists, and to encourage initiation and publication of clinical studies.

Program 2

Expenses: $65,944 Revenue: $103,636

The Organization holds international, regional, and virtual meetings and conferences to provide updates for medical professionals on advances in clinical knowledge, treatment techniques, and the...

The Organization holds international, regional, and virtual meetings and conferences to provide updates for medical professionals on advances in clinical knowledge, treatment techniques, and the opportunity for collaboration between scientists, physicians, and other professionals who care for patients with Lyme and associated vector-borne diseases.

Program 3

Revenue: $109,169

ILADS members receive access to a members-only discussion forum, complementary webinars, a members-only newsletter, opportunities to join committees and network with medical professionals with...

ILADS members receive access to a members-only discussion forum, complementary webinars, a members-only newsletter, opportunities to join committees and network with medical professionals with similar interests and concerns, as well as discounts, on courses, events, and the Physician Training Program.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $109,419

Program Service Revenue $773,457

Investment Income $8,218

Other Revenue $100,500

TOTAL REVENUE $991,594

Expense Breakdown

Grants Paid $0

Salaries & Benefits $491,087

Fundraising Expenses $0

Program Expenses $398,833

Other Expenses $535,388

TOTAL EXPENSES $1,026,475

Year-over-Year Comparison

	2023	2022	Change
Revenue	$991,594	$948,069	+0.0%
Expenses	$1,026,475	$837,459	+0.2%
Net Income	$-34,881	$110,610	-1.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$168,289

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Sarah Quillen ED Feb-Dec	CEO	35.00	Officer	$159,628	$0	$159,628
Barbara Buchman	Former Executive Director	1.00		$145,438	$0	$145,438
William Grubb Jan-Apr	CFO	9.00	Officer	$8,661	$0	$8,661
Steven Bock MD	President	1.00	Director	$0	$0	$0
Amy Offutt MD	Vice President	1.00	Director	$0	$0	$0
Casey Kelley MD	Treasurer	1.00	Director	$0	$0	$0
Christine Saba PharmD MD	Secretary	1.00	Director	$0	$0	$0
Omar Morales MD	Director	1.00	Director	$0	$0	$0
Jody Greenfield DO	Director	1.00	Director	$0	$0	$0
Eboni Cornish MD	Director	1.00	Director	$0	$0	$0
B Robert Mozayeni MD	Director	1.00	Director	$0	$0	$0
Michele Deantonio MD	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	No data	No data	No data	No data
2023	$991,594	$1,026,475	$473,998	$-34,881
2022	$948,069	$837,459	$415,853	$110,610
2021	$778,247	$831,556	$331,647	$-53,309
2020	$649,107	$922,463	$398,467	$-273,356

International Lyme and Assoc Disease Soc